Health Care & Life Sciences » Biotechnology | Edge Therapeutics Inc.

Edge Therapeutics Inc.

Edge Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.9
Market Cap
$25.62 M
Shares Outstanding
31.25 M
Public Float
21.22 M

Profile

Address
300 Connell Drive
Berkeley Heights New Jersey 07922
United States
Employees -
Website http://www.edgetherapeutics.com
Updated 09/14/2018
Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A.

Financials

View All

Brian A. Leuthner
President, Chief Executive Officer & Director
Sol J. Barer
Chairman